IQVIA information

IQVIA Holdings, Inc.
Company type	Public
Traded as	NYSE: IQV; S&P 500 component;
Industry	Contract Research Organization; Pharmaceutical Service, AI, IT, Consulting
Founded	1982; 42 years ago
Founder	Dennis Gillings
Headquarters	Durham, North Carolina, U.S.
Key people	Ari Bousbib; (Chairman & CEO)
Products	Strategy & Operation Consulting, Support services for pharmaceutical, biotech and medical companies and individuals
Revenue	US$15.4 billion (2023)
Operating income	US$1.85 billion (2023)
Net income	US$1.096 billion (2023)
Total assets	US$36.44 billion (2023)
Total equity	US$8.04 billion (2023)
Number of employees	c. 86,000 (October 2023)
Website	iqvia.com
	Footnotes / references;

IQVIA, formerly Quintiles and IMS Health, Inc.,^[6] is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021.^[6] As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).^[7]^[8]

^ "IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance".
^ ^a ^b "IQVIA Holdings Operating Income 2011-2023 | IQV".
^ "IQVIA Holdings Inc. (IQV) Statistics & Valuation Metrics".
^ "IQVIA Holdings: Number of Employees 2011-2023 | IQV".
^ "IQVIA Holdings, Inc. 2021 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. 16 February 2022.
^ ^a ^b "QuintilesIMS is now IQVIA". Business Wire. 6 November 2017. Retrieved 6 November 2017.
^ Melissa Fassbender (9 November 2017). "QuintilesIMS now IQVIA as it aims to 'outpace the inevitable progress of change'". Outsourcing-Pharma.com; William Reed Business Media Ltd. Retrieved 17 December 2017.
^ "Articles about IQVIA". BioSpace. Retrieved 2023-11-02.

[1] "IQVIA Reports First-Quarter 2023 Results; Reaffirms Full-Year 2023 Guidance".

[macrotrends.net-2] "IQVIA Holdings Operating Income 2011-2023 | IQV".

[3] "IQVIA Holdings Inc. (IQV) Statistics & Valuation Metrics".

[4] "IQVIA Holdings: Number of Employees 2011-2023 | IQV".

[report-5] "IQVIA Holdings, Inc. 2021 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. 16 February 2022.

[bw-6] "QuintilesIMS is now IQVIA". Business Wire. 6 November 2017. Retrieved 6 November 2017.

[7] Melissa Fassbender (9 November 2017). "QuintilesIMS now IQVIA as it aims to 'outpace the inevitable progress of change'". Outsourcing-Pharma.com; William Reed Business Media Ltd. Retrieved 17 December 2017.

[8] "Articles about IQVIA". BioSpace. Retrieved 2023-11-02.

IQVIA information

and 22 Related for: IQVIA information

IQVIA

IMS Health

Contract research organization

List of largest selling pharmaceutical products

Pharmacies in the United States

Accenture

Tech Mahindra

Ipsos

Optum

Research Triangle

HCLTech

Indegene

Wipro

UnitedHealth Group

Russell 1000 Index

Washington metropolitan area

Veeva Systems

Clarivate

Google Health

West Lothian

Medidata Solutions

LTIMindtree